InnovaDerma (IDP) Share Price, News & Analysis

Company Overview

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 5,000 shs
• Average Volume: 106,039 shs
• Market Capitalization: £8.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 9/30/2020
• Today: 8/02/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: LON:IDP
• CIK: N/A
• Web: www.innovaderma.com
• Phone: 61 3 9863 8030
• Fax: N/A
• Employees: 8,720
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 55.52
• Current Ratio: 1.93
• Quick Ratio: 1.04

Sales & Book Value

• Annual Sales: £9.82 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.92
• Book Value: GBX 7.90 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 28,058,000
• Free Float: N/A
• Market Cap: £8.14 million
• Optionable: Not Optionable
• Beta: N/A